Facilitating Clinical Studies in Rare Diseases.

Area of Science:

• Rare disease research
• Patient advocacy
• Clinical study infrastructure

Background:

• Despite advances, many rare diseases lack effective treatments and complete etiological understanding.
• Patient outcomes are hindered by incomplete incidence and prevalence data.
• Over 6000 rare diseases exist, necessitating scalable research approaches.

Purpose of the Study:

• To highlight the critical need for stakeholder involvement, particularly patient groups, in rare disease research.
• To emphasize the importance of streamlined infrastructure for multi-site clinical studies.
• To advocate for a group-based, rather than single-disease, research strategy.

Main Methods:

• Engaging all stakeholders, especially patient groups.
• Developing streamlined infrastructure for multi-site clinical studies.
• Fostering multi-disciplinary teams focused on disease groups.
• Collecting standardized data for meta-analyses and data sharing.
• Establishing central data management and coordinating centers.

Main Results:

• Active involvement of patient groups is crucial for advancing rare disease research.
• Streamlined infrastructure and multi-disciplinary teams enhance study efficiency.
• Standardized data collection and central management improve data quality and facilitate sharing.
• Platform-based approaches for disease groups are more impactful than single-disease focus.

Conclusions:

• Effective rare disease research necessitates patient engagement and robust infrastructure.
• Collaborative, standardized, and group-focused research platforms are essential for developing treatments.
• A shift towards supporting groups of rare diseases will accelerate progress and improve patient health.